Prospective Assessment of Quality of Life of Female Cancer Patients

Greimel, Eva; Thiel, I; Peintinger, Florentia; Cegnar, I.; Pongratz, E.

doi:10.1006/gyno.2002.6586

Cited by 124 publications

(98 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A study by Miller et al, comparing healthy patients with those who survived a gynecologic malignancy (51 cervical cancers, 24 uterine cancer and 10 ovarian cancers) showed that there were no overall differences in quality of life [30]. During follow-up after treatment for gynecological cancer an improvement on all quality of life scales was observed [31].…”

Section: Discussionmentioning

confidence: 99%

A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy

Oonk

Bock

et al. 2009

Gynecologic Oncology

View full text Add to dashboard Cite

A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy Oonk, M. H. M.; van Os, M. A.; de Bock, G. H.; de Hullu, J. A.; Ansink, A. C.; van der Zee, A. G. J. Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Objectives. The SLN-procedure has been introduced in vulvar cancer treatment to reduce morbidity and thereby improve quality of life. Aim of this study was to compare quality of life in vulvar cancer patients who were treated with a SLN-procedure only to those who underwent inguinofemoral lymphadenectomy. Moreover, it was evaluated what patients would advise relatives on the application of the SLN-procedure in light of possible false negative results.Methods. Patients who participated in the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) were invited to fill out three questionnaires: the EORTC QLQ-C30, a vulvar specific questionnaire and a questionnaire about the opinion of patients on new treatment options. Patients who only underwent SLN-procedure were compared to those who subsequently underwent inguinofemoral lymphadenectomy because of a positive SLN.Results. With a response rate of 85%, 35 patients after the SLN-procedure and 27 patients after inguinofemoral lymphadenectomy filled out the questionnaires. No difference in overall quality of life was observed between the two groups. The major difference was the increase in complaints of lymphedema of the legs after inguinofemoral lymphadenectomy. The majority of patients would advise the SLN-procedure to relatives. Patients after inguinofemoral lymphadenectomy were more reserved concerning the acceptable false negative rate of a new diagnostic procedure.Conclusions. Patients who underwent the SLN-procedure report less treatment related morbidity compared to those who underwent inguinofemoral lymphadenectomy. However, this did not influence overall quality of life. Furthermore, patients who underwent inguinofemoral lymphadenectomy are more reserved in advising the SLN-procedure to relatives.

show abstract

Section: Discussionmentioning

confidence: 99%

A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy

Oonk

Bock

et al. 2009

Gynecologic Oncology

View full text Add to dashboard Cite

show abstract

“…However, it is easily applied and can be summed into a single score while retaining its domain-specific properties. It has been used worldwide in various cancers (Greimel et al, 2002;Erridge et al, 2005) including gastric cancer (Kusche et al, 1987; Buhl et al, 1990). Our treatment-specific instrument, which was modified from Korenaga's study for Japanese gastric cancer patients, is a short questionnaire, which has proved to be reliable in implementation (Wu et al, 1997a(Wu et al, , 2000 and in current study (Cronbach's a-scores 0.67).…”

Section: Discussionmentioning

confidence: 99%

Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial

Chiou

et al. 2008

Br J Cancer

View full text Add to dashboard Cite

Quality of life (QOL) was studied in gastric cancer patients treated on a randomised, controlled trial comparing D1 (level 1) with D3 (levels 1, 2 and 3) lymphadenectomy. A total of 221 patients were randomly assigned to D1 (n ¼ 110) and D3 (n ¼ 111) surgery. Quality-of-life assessments included functional outcomes (a 14-item survey about treatment-specific symptoms) and health perception (Spitzer QOL Index) was performed before and after surgery at disease-free status. Patients suffered from irrelative events such as loss of partners was excluded thereafter. Main analyses were done by intention-to-treat. Thus, 214 D1 (106/ 110 ¼ 96.4%) and D3 (108/111 ¼ 97.3%) R0 patients were assessed. Longitudinal analysis showed that functional outcomes decreased at 6 months after surgery and increased over time thereafter, while health perceptions increased over time in general. On the basis of linear mixed model analyses, patients having total gastrectomy, advanced cancer and hemipancreaticosplenectomy, but not complications had poorer QOL than those without. D1 and D3 patients showed no significant difference in QOL. The results suggest that changes of QOL were largely due to scope of gastric resection, disease status and distal pancreaticosplenectomy, rather than the extent of lymph node dissection. This indicates that nodal dissection can be performed for a potentially curable gastric cancer.

show abstract

“…Hamilton, (1999) reported that the frequently used multimodality treatment strategy often predisposed women to depression and heightened anxiety. Greimel et al (2002) concluded that global HRQL, emotional functioning, and role-functioning remained low throughout the course of disease, up to one year after completion of treatment. Doyle et al,(2001), who observed the smallest benefit of palliative chemotherapy with a score of 6.6% on a seven-point scale for the physical function and 2.2% for the global QL question.…”

Section: Quality Of Life In Ovarian Cancer Patients Choosing To Receimentioning

confidence: 98%

Quality of Life in Ovarian Cancer Patients Choosing to Receive Salvage Chemotherapy or Palliative Treatment

Srisuttayasathien

Khemapech²

2013

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Prospective Assessment of Quality of Life of Female Cancer Patients

Cited by 124 publications

References 21 publications

A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy

A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy

Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial

Quality of Life in Ovarian Cancer Patients Choosing to Receive Salvage Chemotherapy or Palliative Treatment

Contact Info

Product

Resources

About